Dexmedetomidine Baxter 200 μg/2 ml, Konzentrat zur Herstellung einer Infusionslösung
7680682490011
CH-68249
Konzentrat
Associated product:
DEXMEDETOMIDINE Baxter conc perf 200 mcg/2ml 5 pce
1 / 3
google
Article details
- Package size
- 5
- Selling units
- 5
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.0 MG | Substance | HBESI |
Authorization holder
Baxter AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 68249
- Drug name
- Dexmedetomidine Baxter 100 μg/ml, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- N05CM18
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 26/10/2022
- Authorization expiration date
- 25/10/2027
- IT Number
- 01.04.1.
- Domain
- Human medicine
Package details
- Description (FR)
- DEXMEDETOMIDINE Baxter conc perf 200 mcg/2ml 5 pce
- Description (DE)
- DEXMEDETOMIDINE Baxter Inf Konz 200 mcg/2ml 5 Stk
- Market launch
- 26/10/2022
- Narcotic (BTM)
- No